InMed Pharmaceuticals Ownership 2024 | Who Owns InMed Pharmaceuticals Now?

Overview RevenueFinancials Chart

Institutional Ownership

0.90%

Insider Ownership

0.58%

Retail Ownership

98.52%

Institutional Holders

3.00

InMed Pharmaceuticals Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
SABBY MANAGEMENT, LLC	3.20%	0.05%	307,236	-54,492	-15.06%	81,571	Jun 30, 2024
VIRTU FINANCIAL LLC	0.90%	0.00%	86,684	86,684	100.00%	23,000	Jun 30, 2024
XTX TOPCO LTD	0.19%	0.00%	17,819	17,819	100.00%	4,731	Jun 30, 2024
HRT FINANCIAL LP	0.17%	-	15,996	15,996	100.00%	4,000	Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD	0.00%	-	200	-	-	54	Jun 30, 2024
BANK OF AMERICA CORP /DE/	0.00%	-	100	-	-	26	Jun 30, 2024
TD WATERHOUSE CANADA INC.	0.00%	-	85	85	100.00%	38	Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.	0.00%	-	32	-9	-21.95%	7	Jun 30, 2024
ALLSQUARE WEALTH MANAGEMENT LLC	0.00%	-	21	-	-	6	Jun 30, 2024
GLOBAL RETIREMENT PARTNERS, LLC	0.00%	-	6	-	-	2	Jun 30, 2024
TORONTO DOMINION BANK	-	-	2	-	-	1	Jun 30, 2024
NATIONAL BANK OF CANADA /FI/	-	-	-	-12	-100.00%	-	Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-28,300	-100.00%	-	Jun 30, 2024
ADVISORNET FINANCIAL, INC	-	-	-	-80	-100.00%	-	Jun 30, 2024
TWO SIGMA SECURITIES, LLC	-	-	-	-15,423	-100.00%	-	Jun 30, 2024
ARMISTICE CAPITAL, LLC	-	-	-	-266,968	-100.00%	-	Jun 30, 2024
UBS GROUP AG	-	-	-	-41	-100.00%	-	Jun 30, 2024
BFSG, LLC	-	-	-	-200	-100.00%	-	Jun 30, 2024
FEDERATION DES CAISSES DESJARDINS DU QUEBEC	-	-	-	-19	-100.00%	-	Jun 30, 2024

InMed Pharmaceuticals's largest institutional shareholder is SABBY MANAGEMENT, LLC, holding 3.20% of the company's total share outstanding, currently valued at $81.57K. The top 10 institutional shareholders own together 4.45% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
SABBY MANAGEMENT, LLC	3.20%	0.05%	307,236	-54,492	-15.06%	81,571	Jun 30, 2024
VIRTU FINANCIAL LLC	0.90%	0.00%	86,684	86,684	100.00%	23,000	Jun 30, 2024
XTX TOPCO LTD	0.19%	0.00%	17,819	17,819	100.00%	4,731	Jun 30, 2024
HRT FINANCIAL LP	0.17%	-	15,996	15,996	100.00%	4,000	Jun 30, 2024
ALLSQUARE WEALTH MANAGEMENT LLC	0.00%	-	21	-	-	6	Jun 30, 2024
TD WATERHOUSE CANADA INC.	0.00%	-	85	85	100.00%	38	Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD	0.00%	-	200	-	-	54	Jun 30, 2024
GLOBAL RETIREMENT PARTNERS, LLC	0.00%	-	6	-	-	2	Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.	0.00%	-	32	-9	-21.95%	7	Jun 30, 2024
BANK OF AMERICA CORP /DE/	0.00%	-	100	-	-	26	Jun 30, 2024
TORONTO DOMINION BANK	-	-	2	-	-	1	Jun 30, 2024
NATIONAL BANK OF CANADA /FI/	-	-	-	-12	-100.00%	-	Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-28,300	-100.00%	-	Jun 30, 2024
ADVISORNET FINANCIAL, INC	-	-	-	-80	-100.00%	-	Jun 30, 2024
TWO SIGMA SECURITIES, LLC	-	-	-	-15,423	-100.00%	-	Jun 30, 2024
ARMISTICE CAPITAL, LLC	-	-	-	-266,968	-100.00%	-	Jun 30, 2024
UBS GROUP AG	-	-	-	-41	-100.00%	-	Jun 30, 2024
BFSG, LLC	-	-	-	-200	-100.00%	-	Jun 30, 2024
FEDERATION DES CAISSES DESJARDINS DU QUEBEC	-	-	-	-19	-100.00%	-	Jun 30, 2024

The largest InMed Pharmaceuticals shareholder by % of total assets is SABBY MANAGEMENT, LLC. The company owns 307.24K shares of InMed Pharmaceuticals (INM), representing 0.05% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
VIRTU FINANCIAL LLC	0.90%	0.00%	86,684	86,684	100.00%	23,000	Jun 30, 2024
XTX TOPCO LTD	0.19%	0.00%	17,819	17,819	100.00%	4,731	Jun 30, 2024
HRT FINANCIAL LP	0.17%	-	15,996	15,996	100.00%	4,000	Jun 30, 2024
TD WATERHOUSE CANADA INC.	0.00%	-	85	85	100.00%	38	Jun 30, 2024
TORONTO DOMINION BANK	-	-	2	-	-	1	Jun 30, 2024
BANK OF AMERICA CORP /DE/	0.00%	-	100	-	-	26	Jun 30, 2024
GLOBAL RETIREMENT PARTNERS, LLC	0.00%	-	6	-	-	2	Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD	0.00%	-	200	-	-	54	Jun 30, 2024
ALLSQUARE WEALTH MANAGEMENT LLC	0.00%	-	21	-	-	6	Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.	0.00%	-	32	-9	-21.95%	7	Jun 30, 2024
NATIONAL BANK OF CANADA /FI/	-	-	-	-12	-100.00%	-	Jun 30, 2024
FEDERATION DES CAISSES DESJARDINS DU QUEBEC	-	-	-	-19	-100.00%	-	Jun 30, 2024
UBS GROUP AG	-	-	-	-41	-100.00%	-	Jun 30, 2024
ADVISORNET FINANCIAL, INC	-	-	-	-80	-100.00%	-	Jun 30, 2024
BFSG, LLC	-	-	-	-200	-100.00%	-	Jun 30, 2024
TWO SIGMA SECURITIES, LLC	-	-	-	-15,423	-100.00%	-	Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-28,300	-100.00%	-	Jun 30, 2024
SABBY MANAGEMENT, LLC	3.20%	0.05%	307,236	-54,492	-15.06%	81,571	Jun 30, 2024
ARMISTICE CAPITAL, LLC	-	-	-	-266,968	-100.00%	-	Jun 30, 2024

As of Jun 30 2024, InMed Pharmaceuticals's largest institutional buyer is VIRTU FINANCIAL LLC. The company purchased 86.68K stocks of INM, valued at $23.00K.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ARMISTICE CAPITAL, LLC	-	-	-	-266,968	-100.00%	-	Jun 30, 2024
SABBY MANAGEMENT, LLC	3.20%	0.05%	307,236	-54,492	-15.06%	81,571	Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-28,300	-100.00%	-	Jun 30, 2024
TWO SIGMA SECURITIES, LLC	-	-	-	-15,423	-100.00%	-	Jun 30, 2024
BFSG, LLC	-	-	-	-200	-100.00%	-	Jun 30, 2024
ADVISORNET FINANCIAL, INC	-	-	-	-80	-100.00%	-	Jun 30, 2024
UBS GROUP AG	-	-	-	-41	-100.00%	-	Jun 30, 2024
FEDERATION DES CAISSES DESJARDINS DU QUEBEC	-	-	-	-19	-100.00%	-	Jun 30, 2024
NATIONAL BANK OF CANADA /FI/	-	-	-	-12	-100.00%	-	Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.	0.00%	-	32	-9	-21.95%	7	Jun 30, 2024
ALLSQUARE WEALTH MANAGEMENT LLC	0.00%	-	21	-	-	6	Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD	0.00%	-	200	-	-	54	Jun 30, 2024
GLOBAL RETIREMENT PARTNERS, LLC	0.00%	-	6	-	-	2	Jun 30, 2024
BANK OF AMERICA CORP /DE/	0.00%	-	100	-	-	26	Jun 30, 2024
TORONTO DOMINION BANK	-	-	2	-	-	1	Jun 30, 2024
TD WATERHOUSE CANADA INC.	0.00%	-	85	85	100.00%	38	Jun 30, 2024
HRT FINANCIAL LP	0.17%	-	15,996	15,996	100.00%	4,000	Jun 30, 2024
XTX TOPCO LTD	0.19%	0.00%	17,819	17,819	100.00%	4,731	Jun 30, 2024
VIRTU FINANCIAL LLC	0.90%	0.00%	86,684	86,684	100.00%	23,000	Jun 30, 2024

As of Jun 30 2024, InMed Pharmaceuticals's biggest institutional seller is ARMISTICE CAPITAL, LLC. The company sold -0.27M shares of INM, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
VIRTU FINANCIAL LLC	0.90%	0.00%	86,684	86,684	100.00%	23,000	Jun 30, 2024
XTX TOPCO LTD	0.19%	0.00%	17,819	17,819	100.00%	4,731	Jun 30, 2024
HRT FINANCIAL LP	0.17%	-	15,996	15,996	100.00%	4,000	Jun 30, 2024

InMed Pharmaceuticals's largest new institutional shareholder by number of shares is VIRTU FINANCIAL LLC, purchased 86.68K shares, valued at $23.00K, as of undefined.

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ARMISTICE CAPITAL, LLC	-	-	-	-266,968	-100.00%	-	Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-28,300	-100.00%	-	Jun 30, 2024
TWO SIGMA SECURITIES, LLC	-	-	-	-15,423	-100.00%	-	Jun 30, 2024
BFSG, LLC	-	-	-	-200	-100.00%	-	Jun 30, 2024
ADVISORNET FINANCIAL, INC	-	-	-	-80	-100.00%	-	Jun 30, 2024
UBS GROUP AG	-	-	-	-41	-100.00%	-	Jun 30, 2024
FEDERATION DES CAISSES DESJARDINS DU QUEBEC	-	-	-	-19	-100.00%	-	Jun 30, 2024
NATIONAL BANK OF CANADA /FI/	-	-	-	-12	-100.00%	-	Jun 30, 2024

InMed Pharmaceuticals's largest sold out institutional shareholder by shares sold is ARMISTICE CAPITAL, LLC, sold -0.27M shares, valued at -, as of undefined.

InMed Pharmaceuticals Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
FIDELITY CONCORD STREET TRUST	0.00%	13,905	-	-	Feb 29, 2024
Blackstone Alternative Investment Funds	0.00%	1,200	-	-	Mar 31, 2023
FIDELITY CONCORD STREET TRUST	0.00%	556	-	-	Feb 29, 2024

InMed Pharmaceuticals's largest mutual fund holder by % of total assets is "FIDELITY CONCORD STREET TRUST", owning 13.90K shares, compromising 0.00% of its total assets.

InMed Pharmaceuticals Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
30 Jun, 24	3	-81.25%
31 Mar, 24	16	14.29%
31 Dec, 23	14	75.00%
30 Sep, 23	8	14.29%
30 Jun, 23	7	-41.67%
31 Mar, 23	12	9.09%
31 Dec, 22	11	37.50%
30 Sep, 22	8	-

As of 30 Jun 24, 3 institutions are holding InMed Pharmaceuticals's shares, representing a decrease of -81.25% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
30 Jun, 24	86,775	-87.35%
31 Mar, 24	685,866	-14.72%
31 Dec, 23	804,231	2895.50%
30 Sep, 23	26,848	70.83%
30 Jun, 23	15,716	-84.44%
31 Mar, 23	100,984	-12.87%
31 Dec, 22	115,894	-12.90%
30 Sep, 22	133,059	-

InMed Pharmaceuticals (INM) has 86.78K shares outstanding as of 30 Jun 24, down -87.35% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
30 Jun, 24	0.90%	1.22%
31 Mar, 24	8.60%	8.46%
31 Dec, 23	10.09%	838.89%
30 Sep, 23	1.10%	491.76%
30 Jun, 23	0.47%	5.13%
31 Mar, 23	3.03%	11.96%
31 Dec, 22	5.04%	15.06%
30 Sep, 22	5.78%	-

As of 30 Jun 24, InMed Pharmaceuticals is held by 0.90% institutional shareholders, representing a 1.22% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
30 Jun, 24	2	-66.67%
31 Mar, 24	6	-33.33%
31 Dec, 23	9	50.00%
30 Sep, 23	6	200.00%
30 Jun, 23	2	-66.67%
31 Mar, 23	6	-25.00%
31 Dec, 22	8	-
30 Sep, 22	8	-

2 institutional shareholders have increased their position in INM stock as of 30 Jun 24 compared to 6 in the previous quarter (a -66.67% decrease).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
30 Jun, 24	-	-100.00%
31 Mar, 24	3	50.00%
31 Dec, 23	2	-
30 Sep, 23	-	-100.00%
30 Jun, 23	1	-
31 Mar, 23	-	-100.00%
31 Dec, 22	2	-
30 Sep, 22	-	-

- institutional shareholders have reduced their position in INM stock as of 30 Jun 24 compared to 3 in the previous quarter (a -100.00% decrease).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
30 Jun, 24	3	-81.25%	86,775	-87.35%	0.90%	1.22%	2	-66.67%	-	-100.00%
31 Mar, 24	16	14.29%	685,866	-14.72%	8.60%	8.46%	6	-33.33%	3	50.00%
31 Dec, 23	14	75.00%	804,231	2895.50%	10.09%	838.89%	9	50.00%	2	-
30 Sep, 23	8	14.29%	26,848	70.83%	1.10%	491.76%	6	200.00%	-	-100.00%
30 Jun, 23	7	-41.67%	15,716	-84.44%	0.47%	5.13%	2	-66.67%	1	-
31 Mar, 23	12	9.09%	100,984	-12.87%	3.03%	11.96%	6	-25.00%	-	-100.00%
31 Dec, 22	11	37.50%	115,894	-12.90%	5.04%	15.06%	8	-	2	-
30 Sep, 22	8	-	133,059	-	5.78%	-	8	-	-	-

InMed Pharmaceuticals Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Aug 02, 2024	MANCINI ALEXANDRA DIANE JANET	other	Consultant	S-Sale	Sell	240	$0.18	$42.31	-
Feb 22, 2024	HULL ANDREW	director	-	P-Purchase	Buy	37,500	$0.39	$14.63K	38,258
Feb 21, 2024	ADAMS ERIC A	director, officer	President & CEO	P-Purchase	Buy	41,600	$0.36	$14.92K	43,959

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Feb 22, 2024	HULL ANDREW	director	-	P-Purchase	Buy	37,500	$0.39	$14.63K	38,258
Feb 21, 2024	ADAMS ERIC A	director, officer	President & CEO	P-Purchase	Buy	41,600	$0.36	$14.92K	43,959

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Aug 02, 2024	MANCINI ALEXANDRA DIANE JANET	other	Consultant	S-Sale	Sell	240	$0.18	$42.31	-
May 28, 2024	WOUDENBERG MICHAEL	officer	Chief Operating Officer	H-ExpireLong	Sell	394	$263.18	$103.69K	75,100
May 28, 2024	HSU ERIC C	officer	Sr. VP, Pre-Clinical Res/Dev	H-ExpireLong	Sell	545	$263.18	$143.43K	52,000
May 28, 2024	ADAMS ERIC A	director, officer	President & CEO	H-ExpireLong	Sell	1,139	$263.18	$299.76K	161,000
Mar 05, 2024	HULL ANDREW	director	-	H-ExpireLong	Sell	42	$307.01	$12.89K	8,542
Mar 05, 2024	HSU ERIC C	officer	Sr. VP, Pre-Clinical Res/Dev	H-ExpireLong	Sell	309	$364.72	$112.70K	52,545
Mar 05, 2024	MANCINI ALEXANDRA DIANE JANET	officer	Sr VP, Clinical Reg Affairs	H-ExpireLong	Sell	121	$312.73	$37.84K	52,485
Feb 27, 2024	Jagpal Netta	officer	Chief Financial Officer		Sell	50,000	$0.37	$18.50K	-

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Aug 02, 2024	MANCINI ALEXANDRA DIANE JANET	other	Consultant	S-Sale	Sell	240	$0.18	$42.31	-
May 28, 2024	WOUDENBERG MICHAEL	officer	Chief Operating Officer	H-ExpireLong	Sell	394	$263.18	$103.69K	75,100
May 28, 2024	HSU ERIC C	officer	Sr. VP, Pre-Clinical Res/Dev	H-ExpireLong	Sell	545	$263.18	$143.43K	52,000
May 28, 2024	ADAMS ERIC A	director, officer	President & CEO	H-ExpireLong	Sell	1,139	$263.18	$299.76K	161,000
Mar 05, 2024	HULL ANDREW	director	-	H-ExpireLong	Sell	42	$307.01	$12.89K	8,542
Mar 05, 2024	HSU ERIC C	officer	Sr. VP, Pre-Clinical Res/Dev	H-ExpireLong	Sell	309	$364.72	$112.70K	52,545
Mar 05, 2024	MANCINI ALEXANDRA DIANE JANET	officer	Sr VP, Clinical Reg Affairs	H-ExpireLong	Sell	121	$312.73	$37.84K	52,485
Feb 27, 2024	Jagpal Netta	officer	Chief Financial Officer		Sell	50,000	$0.37	$18.50K	-
Feb 22, 2024	HULL ANDREW	director	-	P-Purchase	Buy	37,500	$0.39	$14.63K	38,258
Feb 21, 2024	ADAMS ERIC A	director, officer	President & CEO	P-Purchase	Buy	41,600	$0.36	$14.92K	43,959
Dec 26, 2023	Johnson Shane Aaron	officer	Sr VP & General Manager	A-Award	Buy	40,000	$0.37	$14.80K	48,000
Dec 26, 2023	Lemerond Nicole	director	-	A-Award	Buy	7,100	$0.37	$2.63K	8,500
Dec 26, 2023	WOUDENBERG MICHAEL	officer	Chief Operating Officer	A-Award	Buy	65,000	$0.37	$24.05K	75,494
Dec 26, 2023	Tegge Jonathan	officer	Interim CFO	A-Award	Buy	30,000	$0.37	$11.10K	31,400
Dec 26, 2023	Grove Janet P	director	-	A-Award	Buy	7,100	$0.37	$2.63K	8,500
Dec 26, 2023	HSU ERIC C	officer	Sr. VP, Pre-Clinical Res/Dev	A-Award	Buy	45,000	$0.37	$16.65K	52,854
Dec 26, 2023	ADAMS ERIC A	director, officer	President & CEO	A-Award	Buy	136,000	$0.37	$50.32K	162,139
Dec 26, 2023	Baldasare Bryan T	director	-	A-Award	Buy	7,100	$0.37	$2.63K	8,500
Dec 26, 2023	MANCINI ALEXANDRA DIANE JANET	officer	Sr VP, Clinical Reg Affairs	A-Award	Buy	45,000	$0.37	$16.65K	52,606
Dec 26, 2023	HULL ANDREW	director	-	A-Award	Buy	7,100	$0.37	$2.63K	8,584

The last insider sell of InMed Pharmaceuticals's stock was made by MANCINI ALEXANDRA DIANE JANET on Aug 02 2024, selling 240 shares at $0.18 per share (valued at $42.31). The last insider buy of INM was made by HULL ANDREW on Feb 22 2024, buying 37,500 shares at $0.39 per share (worth $14.63K).

InMed Pharmaceuticals Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q3 2024	-	1	-
Q2 2024	-	3	-
Q1 2024	2	4	50.00%
Q4 2023	10	1	1000.00%
Q3 2023	-	1	-
Q2 2023	-	3	-
Q1 2023	-	3	-
Q4 2022	16	6	266.67%
Q3 2022	1	-	-
Q2 2022	2	5	40.00%
Q1 2022	4	9	44.44%
Q4 2021	11	2	550.00%
Q3 2021	3	-	-
Q4 2020	10	10	100.00%
Q1 2020	-	1	-
Q3 2019	-	1	-
Q2 2019	-	3	-
Q1 2019	-	5	-
Q4 2018	-	1	-
Q3 2018	-	1	-

0 total buy trades, and 1 total sell trades (buy/sell ratio of 0.00%) were made by InMed Pharmaceuticals's insiders, as of Q3 2024.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q3 2024	-	1	-
Q2 2024	-	-	-
Q1 2024	2	-	-
Q4 2023	-	-	-
Q3 2023	-	-	-
Q2 2023	-	-	-
Q1 2023	-	-	-
Q4 2022	-	-	-
Q3 2022	-	-	-
Q2 2022	2	-	-
Q1 2022	2	-	-
Q4 2021	2	-	-
Q3 2021	3	-	-
Q4 2020	-	-	-
Q1 2020	-	-	-
Q3 2019	-	-	-
Q2 2019	-	-	-
Q1 2019	-	-	-
Q4 2018	-	-	-
Q3 2018	-	-	-

As of Q3 2024, Insider owners conducted 0 open market buy trades and 1 open market sell trades of InMed Pharmaceuticals's stocks.

InMed Pharmaceuticals Peer Ownership

Ticker	Company
ZVSA	ZyVersa Therapeutics, Inc.
BDRX	Biodexa Pharmaceuticals Plc
GOVX	GeoVax Labs, Inc.
VIRI	Virios Therapeutics, Inc.
ICU	SeaStar Medical Holding Corporation
PHIO	Phio Pharmaceuticals Corp.
REVB	Revelation Biosciences, Inc.
QNRX	Quoin Pharmaceuticals, Ltd.
TNXP	Tonix Pharmaceuticals Holding Corp.
SGTX	Sigilon Therapeutics, Inc.
VRAX	Virax Biolabs Group Limited
ALLR	Allarity Therapeutics, Inc.
IMMX	Immix Biopharma, Inc.
SONN	Sonnet BioTherapeutics Holdings, Inc.
DRUG	Bright Minds Biosciences Inc.
PALI	Palisade Bio, Inc.
ATNF	180 Life Sciences Corp.

INM Ownership FAQ

Who Owns InMed Pharmaceuticals?

InMed Pharmaceuticals is owned by institutional shareholders (0.90%), insiders (0.58%), and public (98.52%). The largest institutional shareholder of InMed Pharmaceuticals is SABBY MANAGEMENT, LLC (3.20% of total shares) and the top mutual fund owner is FIDELITY CONCORD STREET TRUST (0.00% of total shares).

Who are the major institutional shareholders of InMed Pharmaceuticals?

InMed Pharmaceuticals's major institutional shareholders are SABBY MANAGEMENT, LLC, VIRTU FINANCIAL LLC, XTX TOPCO LTD, HRT FINANCIAL LP, and QUBE RESEARCH & TECHNOLOGIES LTD. The top five shareholders own together 4.45% of the company's share outstanding.

How many InMed Pharmaceuticals shareholders are there?

As of Jun 2024, there are 3 institutional shareholders of InMed Pharmaceuticals.

What percentage of InMed Pharmaceuticals is owned by SABBY MANAGEMENT, LLC?

SABBY MANAGEMENT, LLC owns 307.24K shares of InMed Pharmaceuticals, representing 3.20% of the company's total shares outstanding, valued at $81.57K (as of Jun 2024).

What percentage of InMed Pharmaceuticals is owned by VIRTU FINANCIAL LLC?

As of Jun 2024, VIRTU FINANCIAL LLC holds 86.68K shares of InMed Pharmaceuticals (INM), compromising 0.90% of the company, valued at $23K.

What percentage of InMed Pharmaceuticals is owned by XTX TOPCO LTD?

XTX TOPCO LTD is the third largest holder of InMed Pharmaceuticals. The company owns 17.82K of the company's shares outstanding (worth $4.73K).